Menu
Infusion 51a is an impact investment fund backing the development of biotech-based solutions that were once a dream.
Since 2015, the fund has been allocating both financial and human capital into vetted opportunities with the potential to disrupt the life-science ecosystem and create revolutionary alternatives for people all around the world.
We lead great ideas from inception to reality.
For us, our word is gold. We are determined to create solid alliances based on integrity and mutual trust. We protect our people fiercely, supporting our portfolio companies at all times and standing up for our shareholders.
We know that we cannot address all global issues, but we can do our best to make huge contributions to revolutionizing healthcare and human life experience.
Our business is our legacy and we aim to leave the world a better place than when we started! We hope you’ll join us on our mission.
Infusion 51a is an impact investment fund backing the development of biotech-based solutions that were once a dream.
Since 2015, the fund has been allocating both financial and human capital into vetted opportunities with the potential to disrupt the life-science ecosystem and create revolutionary alternatives for people all around the world.
We lead great ideas from inception to reality.
For us, our word is gold. We are determined to create solid alliances based on integrity and mutual trust. We protect our people fiercely, supporting our portfolio companies at all times and standing up for our shareholders.
We know that we cannot address all global issues, but we can do our best to make huge contributions to revolutionizing healthcare and human life experience.
Our business is our legacy and we aim to leave the world a better place than when we started! We hope you’ll join us on our mission.
1
We adapt our processes and decisions when necessary, embracing that change is inherent to moving forward; yet, under no circumstances will our ethics and culture be compromised or tread on.
4
We are different! We’re not afraid to say it!
Any business can chase profits and margins, but ours purposefully seeks out philanthropic opportunities in all our investments.
2
We do our jobs with passion and dignity because entire families depend on the decisions we make today.
5
We are determined, focused and never take our eyes off the prize. Our discipline and dedicated mentality is our superpower, easily observable in each and every member of our team.
3
We understand no journey is without its pitfalls. We know that the only way to get where we want to be is by taking steps without apprehension and continuously learning.
1
We adapt our processes and decisions when necessary, embracing that change is inherent to moving forward; yet, under no circumstances will our ethics and culture be compromised or tread on.
2
We do our jobs with passion and dignity because entire families depend on the decisions we make today.
3
We understand no journey is without its pitfalls. We know that the only way to get where we want to be is by taking steps without apprehension and continuously learning.
4
We are different! We’re not afraid to say it!
Any business can chase profits and margins, but ours purposefully seeks out philanthropic opportunities in all our investments.
5
We are determined, focused and never take our eyes off the prize. Our discipline and dedicated mentality is our superpower, easily observable in each and every member of our team.
We are living proof of what hard work can accomplish. We’ve built businesses from the ground up and successfully navigated through all kinds of challenges. Our journey has taught us not to settle for the ordinary and to always rise to the challenges of the future.
Global markets expert focused on key positioning and investment strategies.
Infusion 51a Co-founder and Chief Investment Officer. International Infusion Co-founder.
Managing Member of the General Partner and the Investment Advisor. Vivacitas Co-founder & Director. Former Theralink Director.
Strategic investments and portfolio expansion. Infusion 51a Co-founder and Chief Financial Officer. International Infusion Co-founder. Managing Member of the General Partner and the Investment Advisor. Vivacitas Co-founder, Director & Interim CFO. Former Theralink Interim CFO.
Our business strength is driven by the many stakeholders involved in our mission. Our strategic alliances make us powerful beyond all measure.
Leading financial advisor with +40 years of experience in corporate
restructuring, with a personal portfolio of +35 companies worldwide. Game changer and unicorn maker.
Doctorate in Biochemistry. Founder, consultant, board member, entrepreneur, and investor in biotechnology, pharmaceutical, animal health, technology, and healthcare-related real estate.
Founder and former CSO of BioAgilytix Labs. Worked in small and large pharmaceutical, biotechnology, and manufacturing companies, including GSK and Bayer. Councilman for Cherry Hills Village, CO
Our diverse and experienced employees are the backbone of Infusion 51a. Each and every member of our organization brings a wealth of knowledge in their chosen fields. It’s this knowledge that enables us to do what we do, and do it well!
Investment management attorney with 20 years of practice focused on hedge funds, private equity funds, fund of funds, real estate funds and investment advisors.
Executive Vice President of Operations and Project Management for the various pharmaceutical companies with +35 years of experience in biopharmaceutics. Founding team member of Aerovance, Inc. which garnered over $60 MUSD, and completed six clinical trials in 3.5 years.
MBA in Business Administration and Bachelor in Pharmaceutical Engineering with experience in the Pharmaceutical Industry, public and private hospitals, and start-up environment and good command of marketing, sales, business operations, training and coaching.
Successful entrepreneur and active investor in various asset classes, including medical and pharmaceutical since 1985. Current Chairman and CEO $300MM exit to GlaxoSmithKline.
Served on George Bush Sr. Administration.
Market research, online lead generation and data mining specialist with experience in different industries like Finance, Technology, Real Estate and Healthcare, in charge of developing new
technology tools and B2B marketing solutions.
Production Engineer, Data Scientist, Business Intelligence and Process Management Specialist
with +7 years of experience developing management solutions in large, medium and small
companies, thriving company equity growth and expansion of economic activities.
Multimedia journalist with +7 years of proven work, with experience in VC and start-ups corporative communications, advertising strategy, trend spotting and forecasting and data storytelling. BA in Mass Communications and MA in Political Communication.
Communication, Marketing and SEO Specialist focused on written media and digital strategies. +4 years of experience working in communication departments and developing successful search engines campaigns.
+30 years of experience raising capital and implementing successful expansion strategies in the Biotech, Pharmaceutical, and MedTech industries. Mark has worked in large, diversified healthcare companies such as Johnson & Johnson and Sanofi S.A. and private equity and startup enterprises.
Entrepreneur, investor and philanthropist. Co-founder of Radio Javan, growing to the world’s largest Persian radio station with over 1,000,000 listeners. 10+ years’ experience in Information Technology sales and business development. Strong believer of impact driven initiatives and community engagement.
Prior Chairman, CEO and Founder of Global Med Technologies, Inc. (GLOB) serving over 30 countries on 4 continents, sold for $74M in public offering. One of the first 10 certified Medical
Review Officers in the country.
Fractional CFO at Chimeron Bio. +30 years of financial expertise with extensive experience with
cash flow optimization, budget creation and administration, due diligence, contract
negotiations, P&L accountability and ERP
Ph.D. in Cellular and Developmental Biology. +30 years as a biopharmaceutical researcher and as a Biotech patent attorney. Developer of various molecular medicine breakthroughs,
including the discovery of molecular mechanism of a murine coat color mutation.
Senior pharmaceutical executive and board member with +25 years of medical device and
biotechnology leadership and long track record of building companies and achieving commercial and business development excellence. Current President and CEO of Assertio, Director for Vault Nano and Board Member at BVI Medical.
Our consultants are globally recognized industry veterans whose experience spans up to four decades, serving as a source of unsurpassed wisdom and strategic thinking.
BS Biochemistry. Experience physician and investor Member of the Forbes Dallas Business
Council. Best Selling Author, Investing and Passive Income Consultant. Former BioWise Capital
Biotech Hedge Fund Manager.
PhD in Biochemestry. Executive Officer at American Society for Investigative Pathology. +20 years of experience as a professor in the University of North Carolina, both in the Department of Pathology and Laboratory Medicine and as a director of Graduate Studies, Molecular and
Cellular Pathology Graduate Program.
There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour, or randomised words which look even slightly believable. If you are going to use a passage of Lorem Ipsum, you need to be sure there is anything embarrassing hidden in the middle of text. All the Lorem Ipsum generators on the Internet tend to repeat predefined chunks as necessary, making this the first true generator on the Internet. It uses a dictionary of over 200 Latin words, combined with a handful of model sentence structures, to generate Lorem Ipsum which looks reasonable. The generated Lorem Ipsum is therefore always free from repetition, injected humour, or non-characteristic words etc.Contrary to popular belief, Lorem Ipsum is not simply random text. It has roots in a piece of classical Latin literature from 45 BC, making it over 2000 years old. Richard McClintock, a Latin professor at Hampden-Sydney College in Virginia, looked up one of the more obscure Latin words, consectetur, from a Lorem Ipsum passage, and going through the cites of the word in classical literature, discovered the undoubtable source.
Internationally acclaimed healthcare executive, surgeon, and medical engineering expert with 25+ years of experience. Former Chair of the American Board of Surgery. Author of 100+ academic articles on cancer-related topics.
PhD. In Microbiology. Professor & Co-Director of the Center for Applied Proteomics and
Molecular Medicine (CAPMM) at George Mason University. Co-founder of 4 life science
companies in the nanotechnology diagnostic and precision medicine space. Co-authored nearly
400 publications, and is a co-inventor on 40 filed and published patents.
Ph.D. in Biochemistry. Research Assistant Professor at the Center for Applied Proteomics and Molecular Medicine focused on the RPPA technology and protein signaling, with publications spanning topics of glioblastoma tumor heterogeneity and evolving RPPA technology and its
applications.
40+ years business expertise; 30+ years in Regulatory Affairs and Drug Development across a range of therapeutic areas in small and large pharma, Due Diligence for new or expanded
ventures specialist. Former Vice President, Global Oncology Regulatory Affairs at Johnson & Johnson. Current President & Principal Consultant at Orvieto Consulting, LLC.
PhD in Pharmaceutical Sciences. MBA in Entrepreneurship. Pharmaceutical Executive with 20+ years of industry experience. Leading clinical development programs from drug discovery to
commercialization. Current Chief Development Officer at Neuraptive Therapeutics.
Get the best industry insights by signing up for our monthly newsletter:
Copyright © 2022 Infusion 51a, LP
Follow us: